As of May 2023 Horizon Therapeutics has a market cap of $22.77 Billion. This makes Horizon Therapeutics the world's 773th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Year | Market cap | Change |
---|---|---|
2023 | $22.77 B | -11.83% |
2022 | $25.82 B | 5.67% |
2021 | $24.44 B | 51.39% |
2020 | $16.14 B | 137.21% |
2019 | $6.80 B | 106.28% |
2018 | $3.29 B | 37.9% |
2017 | $2.39 B | -8.29% |
2016 | $2.60 B | -24.6% |
2015 | $3.46 B | 116.42% |
2014 | $1.59 B | 217.45% |
2013 | $0.50 B | 250.22% |
2012 | $0.14 B | 84.11% |
2011 | $78.11 M |
On May 27th, 2023 the market cap of Horizon Therapeutics was reported to be:
Name | Market cap | Market cap differencediff. | Country |
---|---|---|---|
![]() Pfizer PFE | $212.26 B | 832.08% | ๐บ๐ธ USA |
![]() Amgen AMGN | $115.91 B | 408.99% | ๐บ๐ธ USA |
![]() Merck MRK | $281.83 B | 1,137.58% | ๐บ๐ธ USA |
![]() AstraZeneca AZN | $229.26 B | 906.74% | ๐ฌ๐ง UK |
![]() Dr. Reddy's RDY | $9.09 B | -60.07% | ๐ฎ๐ณ India |